The COVID-19 pandemic substantially altered circulation of respiratory pathogens worldwide. Longitudinal, multispecies surveillance spanning the pandemic and post-pandemic transition is limited. This study used a multiplex molecular panel to characterize temporal changes in respiratory pathogen ecology in a single hospital in Tokyo from January 2020 through March 2026.
The authors analyzed 19,968 respiratory samples tested with the BioFire® FilmArray® Respiratory Panel. Samples were collected at a hospital in Tokyo between January 2020 and March 2026. Analyses included overall pathogen detection rates, temporal trends in pathogen circulation, age-stratified distributions, frequency of co-detections, pairwise pathogen association testing, and assessment of basic clinical parameters. The report is a preprint and has not undergone peer review.
Overall detection and co-detection
At least one respiratory pathogen was detected in 27.8% of tests. Among positive specimens, co-detection of two or more pathogens occurred in 14.0%. Co-detections were significantly more frequent in younger patients.
Temporal and pathogen-specific trends
Following relaxation of COVID-19–related public health measures, respiratory pathogens resurged but not synchronously. Influenza virus circulation remained markedly suppressed through late 2022 and then re-emerged, producing successive large seasonal epidemics. Other pathogens demonstrated distinct patterns of rebound: respiratory syncytial virus (RSV), human metapneumovirus, and Mycoplasma pneumoniae each exhibited their own timing and resurgence dynamics rather than a uniform return across agents.
Age distribution
Pathogen distributions varied by age group. Human rhinovirus/enterovirus remained predominant among young children. SARS-CoV-2 predominated in older adults. These age-specific differences were apparent over the study period and contributed to variation in co-detection frequencies and pairwise association patterns.
Pairwise associations and period dependence
Pairwise analysis identified both positive and negative associations between pathogens. The direction and magnitude of these associations differed across age groups and across pandemic versus post-pandemic periods, indicating that inter-pathogen relationships are context dependent and may shift as population immunity, behavior, and control measures change.
Clinical parameters
The surveillance incorporated evaluation of basic clinical parameters alongside pathogen detection and co-detection; however, the preprint presents summary statements about clinical patterns rather than detailed clinical outcome data in the abstract. Detailed clinical findings and parameter-specific results are reported in the full manuscript and supplementary materials.
Younger patients had higher rates of co-detection. The predominance of human rhinovirus/enterovirus in children contrasts with the predominance of SARS-CoV-2 in older adults, and these age-dependent distributions influenced observed co-detection and pairwise association statistics. The study highlights that children and older adults experienced different pathogen exposure and circulation patterns during and after the pandemic, which has implications for diagnostics and infection control in age-stratified clinical settings.
Analyses of pairwise pathogen associations revealed heterogeneous relationships: some pathogen pairs showed positive associations while others were negatively associated. Importantly, these association patterns were not static; they varied by patient age and by study period (pandemic versus post-pandemic phases). The findings suggest that competitive or facilitative interactions among respiratory agents, combined with behavioral and population-immunity changes, shaped post-pandemic circulation patterns.
Between 2020 and 2026, respiratory pathogen circulation in Tokyo changed substantially during the transition from the COVID-19 pandemic to the post-pandemic period. Resurgence of respiratory agents was asynchronous and pathogen-specific, with clear age-dependent differences in distribution and co-detection. The authors recommend continued molecular surveillance to track evolving circulation, to refine infection control strategies, and to inform public health responses in the post-pandemic era. Because this report is a preprint, the results should be interpreted with caution until peer review is completed.
Ethical approval for the study was provided by the Ethics Review Committee of the Japan Institute for Health Security (JIHS), Japan (NCGM-004190). The authors state that patient consent and relevant institutional approvals were obtained and that methods followed applicable guidelines and regulations. Data that support the findings, excluding subjects restricted by privacy or ethics considerations, are available from the corresponding authors upon reasonable request. Funding was provided by the NCGM Collaborative Research Fund (Grant Number 22K900C). The authors declared no competing interests.